Published in BMC Neurol on March 29, 2012
The development of carotid stent material. Interv Neurol (2015) 0.81
Association of CYP2C19 Polymorphisms with the Clinical Efficacy of Clopidogrel Therapy in Patients Undergoing Carotid Artery Stenting in Asia. Sci Rep (2016) 0.80
Physician specialty and variation in carotid revascularization technique selected for Medicare patients. J Vasc Surg (2015) 0.79
Current trends of major arterial diseases in Korea: based on data from the Health Insurance Review and Assessment Service. Ann Surg Treat Res (2016) 0.78
Impact of Clinical Trial Results on the Temporal Trends of Carotid Endarterectomy and Stenting From 2002 to 2014. Stroke (2016) 0.75
The impact of endovascular repair on specialties performing abdominal aortic aneurysm repair. J Vasc Surg (2015) 0.75
Regional variation in patient selection and treatment for carotid artery disease in the Vascular Quality Initiative. J Vasc Surg (2017) 0.75
Impact of alternative medical device approval processes on costs and health. Clin Transl Sci (2014) 0.75
Cardiac damage after carotid intervention: a meta-analysis after a decade of randomized trials. J Anesth (2014) 0.75
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med (1991) 18.33
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA (1995) 15.80
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation (2008) 15.35
Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med (2006) 12.90
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59
Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet (1998) 10.64
Short-term outcome after stenting versus endarterectomy for symptomatic carotid stenosis: a preplanned meta-analysis of individual patient data. Lancet (2010) 4.07
Efficacy of carotid endarterectomy for asymptomatic carotid stenosis. The Veterans Affairs Cooperative Study Group. N Engl J Med (1993) 3.93
Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol (2008) 3.91
Race and sex differences in the distribution of cerebral atherosclerosis. Stroke (1996) 2.35
Regional variation in carotid artery stenting and endarterectomy in the Medicare population. Circ Cardiovasc Qual Outcomes (2009) 2.21
Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST). Lancet Neurol (2011) 2.15
Veterans Administration Acute Stroke (VASt) Study: lack of race/ethnic-based differences in utilization of stroke-related procedures or services. Stroke (2003) 1.82
Safety and efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy: a Cochrane systematic review of the randomized evidence. Stroke (2005) 1.80
Low risk of ipsilateral stroke in patients with asymptomatic carotid stenosis on best medical treatment: a prospective, population-based study. Stroke (2009) 1.75
Trends, complications, and mortality in peripheral vascular surgery. J Vasc Surg (2006) 1.72
Age and outcomes after carotid stenting and endarterectomy: the carotid revascularization endarterectomy versus stenting trial. Stroke (2011) 1.69
Evidence-based treatment of carotid artery stenosis. Neurosurg Focus (2011) 1.44
Stent-protected angioplasty in asymptomatic carotid artery stenosis vs. endarterectomy: SPACE2 - a three-arm randomised-controlled clinical trial. Int J Stroke (2009) 1.27
Impact of race on the outcome of carotid endarterectomy: a population-based analysis of 9,842 recent elective procedures. Ann Surg (2000) 1.13
Changes in the use of carotid revascularization among the medicare population. Arch Surg (2008) 1.07
Does race predict short-term mortality after carotid surgery? The results of a meta-analysis. J Natl Med Assoc (2002) 0.94
Current management of extracranial carotid occlusive disease. J Am Coll Surg (2009) 0.90
Patient risk perceptions for carotid endarterectomy: which patients are strongly averse to surgery? J Vasc Surg (2004) 0.86
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2010) 6.93
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial. Lancet (2010) 4.72
The importance of population-wide sodium reduction as a means to prevent cardiovascular disease and stroke: a call to action from the American Heart Association. Circulation (2011) 2.89
Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial. J Am Coll Cardiol (2007) 2.56
An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the CHARISMA trial. Eur Heart J (2007) 2.31
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. Circulation (2004) 2.16
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol (2005) 2.11
Deaf sign language users, health inequities, and public health: opportunity for social justice. Prev Chronic Dis (2011) 1.66
American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 update: a scientific statement for public health practitioners, healthcare providers, and health policy makers. Circulation (2013) 1.66
Fatty acids in cardiovascular health and disease: a comprehensive update. J Clin Lipidol (2012) 1.59
Community participatory research with deaf sign language users to identify health inequities. Am J Public Health (2011) 1.55
Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. J Am Coll Cardiol (2003) 1.55
Lateral automobile impacts and the risk of traumatic brain injury. Ann Emerg Med (2004) 1.54
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. Circulation (2004) 1.44
Short communication: risk of elevated total cholesterol/high-density lipoprotein cholesterol ratio after antiretroviral therapy in HIV/hepatitis C virus patients. AIDS Res Hum Retroviruses (2012) 1.40
Impact of communication on preventive services among deaf American Sign Language users. Am J Prev Med (2011) 1.23
Who is maintaining weight in a middle-aged population in Sweden? A longitudinal analysis over 10 years. BMC Public Health (2007) 1.19
Prevention Conference VI: Diabetes and Cardiovascular disease: Writing Group I: epidemiology. Circulation (2002) 1.14
CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the population science discussion group. Circulation (2004) 1.13
Incidence of coronary artery disease in siblings of patients with premature coronary artery disease: 10 years of follow-up. Am J Cardiol (2007) 1.11
Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator. Mayo Clin Proc (2008) 1.09
Training medical students in community health: a novel required fourth-year clerkship at the University of Rochester. Acad Med (2008) 1.08
Metabolic syndrome components in african-americans and European-american patients and its relation to coronary artery disease. Am J Cardiol (2007) 1.07
Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol. J Lipid Res (2006) 1.05
Effects of moderate-fat (from monounsaturated fat) and low-fat weight-loss diets on the serum lipid profile in overweight and obese men and women. Am J Clin Nutr (2004) 1.05
How much do we need to worry about venous thromboembolism after hospital discharge? A study of colorectal surgery patients using the National Surgical Quality Improvement Program database. Dis Colon Rectum (2010) 1.04
Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort. Radiat Res (2010) 1.01
Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states. Am J Clin Nutr (2007) 1.01
High obesity incidence in northern Sweden: how will Sweden look by 2009? Eur J Epidemiol (2006) 0.99
Comparison of the dose-response relationships of 2 lipid-lowering agents: a Bayesian meta-analysis. Am Heart J (2003) 0.98
The relationship between retinal microvascular abnormalities and coronary heart disease: a review. Am J Med (2010) 0.97
Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a]. J Lipid Res (2006) 0.96
Elevated blood pressure, race/ethnicity, and C-reactive protein levels in children and adolescents. Pediatrics (2008) 0.96
High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans. J Clin Endocrinol Metab (2008) 0.94
Synergistic role of inflammation and insulin resistance as coronary artery disease risk factors in African Americans and Caucasians. Atherosclerosis (2008) 0.93
Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians. J Lipid Res (2002) 0.93
Are central institutional review boards the solution? The National Heart, Lung, and Blood Institute Working Group's report on optimizing the IRB process. Acad Med (2012) 0.93
ApoE genotype affects allele-specific apo[a] levels for large apo[a] sizes in African Americans: the Harlem-Basset Study. J Lipid Res (2006) 0.91
Comparison of C-reactive protein and metabolic syndrome as cardiovascular risk factors in African-Americans and European-Americans. Am J Cardiol (2008) 0.91
ApoE and ApoC-I polymorphisms: association of genotype with cardiovascular disease phenotype in African Americans. J Lipid Res (2009) 0.91
Identifying emerging research collaborations and networks: method development. Eval Health Prof (2013) 0.90
Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillators. Cardiol J (2010) 0.90
Adiponectin levels are associated with coronary artery disease across Caucasian and African-American ethnicity. Transl Res (2007) 0.89
Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population. Atherosclerosis (2010) 0.88
Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians. Transl Res (2011) 0.88
Age as a modulator of inflammatory cardiovascular risk factors. Arterioscler Thromb Vasc Biol (2011) 0.88
Our expanding view of platelet functions and its clinical implications. J Cardiovasc Transl Res (2010) 0.88
Novel therapeutic targets for preserving a healthy endothelium: strategies for reducing the risk of vascular and cardiovascular disease. Cardiol J (2011) 0.88
Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians. J Clin Endocrinol Metab (2010) 0.86
Associations between omega-3 poly-unsaturated fatty acids from fish consumption and severity of depressive symptoms: an analysis of the 2005-2008 National Health and Nutrition Examination Survey. Prostaglandins Leukot Essent Fatty Acids (2012) 0.86
Usefulness of apolipoprotein B/apolipoprotein A-I ratio to predict coronary artery disease independent of the metabolic syndrome in African Americans. Am J Cardiol (2010) 0.85
Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II. J Gen Intern Med (2006) 0.85
Cardiovascular Health in the Developing World: Community Perceptions from Carriacou, Grenada. CVD Prev Control (2008) 0.85
The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians. Atherosclerosis (2008) 0.82
Knowledge, perception, and behaviors of relatives of people with premature heart disease: a systematic literature review. Circulation (2011) 0.82
AJC editor's consensus: rheumatoid arthritis and atherosclerotic cardiovascular disease. Am J Cardiol (2010) 0.82
Task Force on Strategic Research Direction: Population/Outcomes/Epidemiology/Social Science Subgroup key science topics report. Circulation (2002) 0.82
Organizing services for cardiovascular prevention. Curr Treat Options Cardiovasc Med (2007) 0.81
An epidemiologic transition of cardiovascular disease risk in Carriacou and Petite Martinique, Grenada: the Grenada Heart Project, 2005-2007. Prev Chronic Dis (2012) 0.81
Independent Associations Between Metabolic Syndrome Severity and Future Coronary Heart Disease by Sex and Race. J Am Coll Cardiol (2017) 0.80
Commentary: What are the benefits of training deaf and hard-of-hearing doctors? Acad Med (2013) 0.79
Prediction of postdischarge venous thromboembolism using a risk assessment model. J Vasc Surg (2013) 0.79
Do disease management programs for patients with coronary heart disease make a difference? Experiences of nine practices. Am J Manag Care (2002) 0.79
Breast cancer risk 55+ years after irradiation for an enlarged thymus and its implications for early childhood medical irradiation today. Cancer Epidemiol Biomarkers Prev (2010) 0.78
Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease. J Am Coll Surg (2005) 0.78
The voltage gates of connexin channels are sensitive to CO(2). Cell Commun Adhes (2003) 0.77
The quality of lifestyle and the quality of life. Arch Intern Med (2011) 0.77
Parenteral fish oil-associated burr cell anemia. J Pediatr (2010) 0.77
A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial. Am Heart J (2005) 0.76
Lp(a) and risk of recurrent cardiac events in obese postinfarction patients. Obesity (Silver Spring) (2008) 0.75
Identification of those at risk for diabetes mellitus can comparative effectiveness research provide the answer? Am J Prev Med (2011) 0.75
Estimating cholesterol treatment rates among individuals with multiple risk factors and without coronary heart disease. Am J Cardiol (2005) 0.75
Aronow's "Should the NCEP III guidelines be changed in elderly and younger persons at high risk for cardiovascular events?" Commentary. J Gerontol A Biol Sci Med Sci (2005) 0.75
Monthly haemostatic factor variability in women and men. Eur J Clin Invest (2014) 0.75
B vitamins and restenosis after coronary angioplasty. N Engl J Med (2002) 0.75
High Density Lipoprotein (HDL) Modulation Targets. Drugs Future (2010) 0.75
Micronutrient Intake Is Inadequate for a Sample of Pregnant African-American Women. J Acad Nutr Diet (2017) 0.75
The value of PRACTISE to improve thrombolysis rates for acute stroke: a 17-year quest. Neurology (2012) 0.75
Combination niacin and statin therapy in primary and secondary prevention of cardiovascular disease. Clin Cardiol (2005) 0.75
Positioning technology to serve global heart health: the Fifth International Heart Health Conference. Eur J Cardiovasc Prev Rehabil (2004) 0.75
Lipoprotein(a): implications for clinical practice. Curr Atheroscler Rep (2005) 0.75
Severe coronary disease in an adult considered at low cardiovascular disease risk with a healthy lifestyle. J Clin Lipidol (2013) 0.75
Liquid chromatographic aqueous product characterization of high-energy electron beam irradiated 2-chlorobiphenyl solutions. Chemosphere (2004) 0.75
In the clinic. Dyslipidemia. Ann Intern Med (2007) 0.75